Alpha Cognition Inc
ACOG
Rang in Aktien
#20188
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aktienkurs
$8.47
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$131.47M
Veränderung (1 Tag)
3.36%
Veränderung (1 Jahr)
68.29%
Land
US
Handel Alpha Cognition Inc (ACOG)
Kategorie
Healthcare
P/B-Verhältnis für Alpha Cognition Inc (ACOG)
P/B-Verhältnis zum October 2026 TTM: -114.63
Laut den neuesten Finanzberichten und dem Aktienkurs von Alpha Cognition Inc beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) -114.63. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei -274.94.
P/B-Verlauf für Alpha Cognition Inc von 2018 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | -114.63 | -53.90% |
| 2023 | -248.67 | -9.55% |
| 2022 | -274.94 | -288.08% |
| 2021 | 146.19 | -97.93% |
| 2020 | 7.05K | 6,164.26% |
| 2019 | 112.47 | 16.25% |
| 2018 | 96.75 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 6.251 | -105.45% |
US
|
|
| 13.2547 | -111.56% |
US
|
|
| 4.208 | -103.67% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -105.39% |
NL
|
